TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 AFTER EXERCISE - COMPARISON TO VENOUS OCCLUSION AND DDAVP

被引:5
|
作者
VENE, N
STEGNAR, M
机构
[1] N. Vene, M. Stegnar, University Clinical Centre, Trnovo Hospital of Internal Medicine
关键词
DDAVP; PAI-1; Physical exercise; t-PA; Venous occlusion;
D O I
10.1016/0268-9499(90)90378-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nineteen healthy young men were subjected randomly to maximal exercise on treadmill, venous occlusion (VO) and infusion of DDAVP on three different mornings. Alter exercise t-PA antigen increased by 2.8 fold, after VO by 5.1 fold and after DDAVP by 2.4 fold (all P<0.01). PAI-1 antigen did not change significantly after any of the stimuli. Therefore, increases in t-PA activity and decreases in PAI-1 activity observed after stimulation were attributed to released t-PA antigen only: increase in t-PA activity after exercise was 2.2 fold lower than that after VO and 1.8 fold higher than after DDAVP. No PAI-1 activity could be detected in 81 9 samples after exercise, in 15 19 samples after VO and in 5/19 after DDAVP. Positive correlations were observed for t-PA antigen release between the three stimuli (VO-DDAVP: r=0.78, P<0.01; exercise-DDAVP: r=0.53, P<0.05; VO-exercise: r=0.30, not significant). It was concluded that maximal exercise as a stimulus of t-PA release is less effective than VO and similar to DDAVP. Divergent alterations of t-PA and PAI-1 antigens after stimulation argue against a common regulation of their acute release from tissue stores. © 1990.
引用
收藏
页码:105 / 107
页数:3
相关论文
共 50 条
  • [21] INTERACTIONS BETWEEN THE FINGER AND KRINGLE-2 DOMAINS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    KANEKO, M
    SAKATA, Y
    MATSUDA, M
    MIMURO, J
    JOURNAL OF BIOCHEMISTRY, 1992, 111 (02): : 244 - 248
  • [22] TISSUE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR AND D-DIMER IN MALIGNANCY
    FERNANDEZ, J
    PARAMO, JA
    CUESTA, B
    HERNANDEZ, M
    PALOMA, MJ
    RIFON, J
    ROCHA, E
    BIOCHEMISTRY, BIOLOGICAL FUNCTIONS, GENE REGULATION AND EXPRESSION, 1988, 801 : 329 - 332
  • [23] THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 BINDING-SITE IN THE KRINGLE-2 DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    KANEKO, M
    MIMURO, J
    MATSUDA, M
    SAKATA, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (03) : 1160 - 1166
  • [24] POSTOPERATIVE CHANGES IN PLASMA TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR
    AOKI, K
    NISHINO, N
    BABA, S
    URANO, T
    TAKADA, A
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (12): : 1039 - 1043
  • [25] IDENTIFICATION OF A CONFORMATIONALLY DISTINCT FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1, ACTING AS A NONINHIBITORY SUBSTRATE FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    DECLERCK, PJ
    DEMOL, M
    VAUGHAN, DE
    COLLEN, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (17) : 11693 - 11696
  • [26] CATHEPSIN-D MEDIATES THE DEGRADATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 COMPLEXES IN MONOCYTES
    SIMON, DI
    XU, H
    VAUGHAN, DE
    CIRCULATION, 1994, 90 (04) : 620 - 620
  • [27] CHARACTERIZATION OF INTERACTION OF ACTIVE-SITE SERINE MUTANTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WITH PLASMINOGEN-ACTIVATOR INHIBITOR-1
    MONGE, JC
    LUCORE, CL
    FRY, ETA
    SOBEL, BE
    BILLADELLO, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (18) : 10922 - 10925
  • [29] TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    MCDONALD, C
    SHUMAN, M
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1985, 366 (09): : 823 - 824
  • [30] TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AFTER KIDNEY-TRANSPLANTATION
    VOLK, C
    LORETH, RM
    ALBERT, FW
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1335 - 1335